Diagnostic value of 99mTc-methylene diphosphonate and 99mTc-pentavalent DMSA compared with 99mTc-sestamibi for palpable breast lesions

Journal of Nuclear Medicine

Volumn 43, Issue 7, 2002, Pages 882-888

  Massardo, Teresa ^a   Alonso, Omar ^a   Kabasakal, Levent ^a   Llamas Olier, Augusto ^a   Shankar, Uma Ravi ^a   Zhu, Huiqing ^a   Delgado, Lucía ^a   González, Patricio ^a   Mut, Fernando ^a   Padhy, Ajit K ^a  

^a HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

Author keywords

99mTc methylene diphosphonate; 99mTc sestamibi; Breast cancer; Pentavalent 99mTc DMSA; Scintimammography

Indexed keywords

MEDRONATE TECHNETIUM TC 99M; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; SUCCIMER TC 99M; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; BREAST TUMOR; CANCER DIAGNOSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FEMALE; HUMAN; ISOTOPE LABELING; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; RADIATION DOSE; SCINTIMAMMOGRAPHY; VALIDATION PROCESS; AXILLA; COMPARATIVE STUDY; LYMPH NODE; MIDDLE AGED; PROSPECTIVE STUDY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY;

AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M DIMERCAPTOSUCCINIC ACID; TECHNETIUM TC 99M MEDRONATE; TECHNETIUM TC 99M SESTAMIBI;

EID: 0035983952     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Can scintimammography reduce "unnecessary" biopsies?
2. 99mTcsestamibi breast imaging: Multicenter trial results
3. Scintimammography with technetium-99m methoxyisobutylisonitrile: Results of a prospective European multicentre trial
4. Role and evaluation of mammography and other imaging methods for breast cancer detection, diagnosis and staging
5. 99mTc MIBI scintimammography in suspected breast cancer
6. The role of Tc99m-sestamibi and other conventional radiopharmaceuticals in breast cancer diagnosis
7. Nuclear medicine techniques for the study of breast cancer
8. Prone scintimammography in patients with suspicion of carcinoma of the breast
9. Technetium 99m-MIBI scintimammography for suspicious breast lesions
10. Technetium-99m-methylene diphosphonate scintimammography to image primary breast cancer
11. Value of 99m-TcMIBI and 99m-Tc(V) DMSA scintigraphy in evaluation of breast mass lesions
12. PET in breast cancer
13. 99mTc methoxyisobutylisonitrile in imaging breast cancer
14. Prediction of the usefulness of combined mammography and scintimammography in suspected primary breast cancer using ROC curves
15. Expression of mediated P-glycoprotein multidrug resistance related to Tc-99m MIBI scintimammography results
16. Correlation between uptake of Tc-99m sestaMIBI and prognostic factors of breast cancer
17. Technetium-99m sestamibi uptake in human breast carcinoma cell lines displaying glutathione-associated drug-resistance
18. Tc 99m(V)DMSA imaging: A new approach to studying metastases from breast carcinoma
19. Analogy between tumor uptake of technetium(V)-99m dimercaptosuccinic acid (DMSA) and technetium-99m-MDP
20. Pentavalent DMSA imaging in patients with bone metastases
21. A new imaging agent for medullary carcinoma of the thyroid
22. Pentavalent Tc-99m dimercaptosuccinic acid imaging of hepatocellular carcinoma
23. Soft-tissue tumors: Diagnosis with Tc-99m (V) dimercaptosuccinic acid scintigraphy
24. 99mTc-MIBI
25. Tc(V)-DMS tumor localization mechanism: A pH-sensitive Tc(V)-DMS-enhanced target/nontarget ratio by glucose-mediated acidosis
26. Estimates of the worldwide incidence of 25 major cancers in 1990
27. Technetium-99m sestamibi scintimammography: The influence of histopathological characteristics, lesion size and the presence of carcinoma in situ in the detection of breast carcinoma
28. Technetium-99m (V)-dimercaptosuccinic acid: Normal accumulation in the breasts
29. Scintimammographic findings of in situ ductal breast carcinoma in a double-phase study with Tc-99m(V) DMSA and Tc-99m MIBI value of Tc-99m(V) DMSA
30. Scintimammography with Tc99m-MDP in the detection of primary breast cancer
31. 99mTc-MDP: Experience of the National Cancer Institute of Naples
32. Technetium-99m methylene diphosphonate scintimammography for evaluation of palpable breast masses
33. Tc-99m MDP scintimammography in palpable and nonpalpable breast lesions: Comparison with mammographic probability of malignancy
34. The comparison of dual phase Tc-99m MIBI and Tc-99m MDP scintimammography in the evaluation of breast masses: Preliminary report
35. A comparison of 99Tcm-MDP and 99Tcm-MIBI in the detection of breast cancer
36. 99mTc-HMDP scintimammography for the diagnosis of breast cancer and its axillary metastases
37. 99mTc-sestamibi
38. Evaluation of Tc-99m based radiopharmaceuticals in diagnosis and management of breast cancer: Comparison of Tc-99m Mibi and Tc-99m DMSA (V) scintimammography
39. 99mTc(V)-DMSA accumulation in gynecomastia
40. Is (99m)Tc-sestamibi scintimammography complementary to conventional mammography for detecting breast cancer in patients with palpable masses?